Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II … – Benzinga
|
Stem Cell Company CardioCell Utilizes BioLife Solutions CryoStor® in Phase II …
Benzinga In the article, titled, Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy, the use of BioLife's clinical grade CryoStor freeze media was disclosed. Details of the … |
